Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000029453 | SCV000052103 | likely pathogenic | Familial hypocalciuric hypercalcemia | 2011-08-18 | criteria provided, single submitter | curation | Converted during submission to Likely pathogenic. |
Athena Diagnostics | RCV002472936 | SCV002771680 | pathogenic | not provided | 2022-08-09 | criteria provided, single submitter | clinical testing | This variant is expected to result in the loss of a functional protein. This variant has not been reported in large, multi-ethnic general populations (http://gnomad.broadinstitute.org). This variant has been identified in at least one individual tested at Athena Diagnostics with clinical features associated with this gene. |
Labcorp Genetics |
RCV002513240 | SCV003001424 | pathogenic | Familial hypocalciuric hypercalcemia; Autosomal dominant hypocalcemia 1 | 2022-11-09 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Arg185Glnfs*72) in the CASR gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in CASR are known to be pathogenic (PMID: 11807402, 14985373, 22422767). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with CASR-related conditions. ClinVar contains an entry for this variant (Variation ID: 35801). For these reasons, this variant has been classified as Pathogenic. |